202 related articles for article (PubMed ID: 32495877)
21. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
23. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
24. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
25. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
[TBL] [Abstract][Full Text] [Related]
26. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
27. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
[TBL] [Abstract][Full Text] [Related]
28. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
29. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
30. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of raf-1 kinase inhibitor protein in oral squamous cell carcinoma and its role in cell metastasis.
Lu MM; Guo XJ; Lyu CQ; Zou DR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12194-12199. PubMed ID: 33336737
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
Yu BX; Zou L; Li S; Du YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
[TBL] [Abstract][Full Text] [Related]
33. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LUCAT1 promotes rowth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA.
Kong Y; Feng Y; Xiao YY; Liu SC; Li XG; Yang QL; Chu WH; Liu JG
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4770-4776. PubMed ID: 31210306
[TBL] [Abstract][Full Text] [Related]
35. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis.
Tong F; Guo J; Miao Z; Li Z
Cancer Biomark; 2021; 30(1):1-12. PubMed ID: 32924983
[TBL] [Abstract][Full Text] [Related]
37. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
39.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
40. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
